Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Accumulated Expenses (2021 - 2025)

Historic Other Accumulated Expenses for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $42.1 million.

  • LifeStance Health's Other Accumulated Expenses fell 264.95% to $42.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year decrease of 264.95%. This contributed to the annual value of $46.9 million for FY2024, which is 3407.4% up from last year.
  • Latest data reveals that LifeStance Health reported Other Accumulated Expenses of $42.1 million as of Q3 2025, which was down 264.95% from $46.9 million recorded in Q2 2025.
  • LifeStance Health's 5-year Other Accumulated Expenses high stood at $91.0 million for Q3 2023, and its period low was $21.8 million during Q1 2022.
  • Over the past 5 years, LifeStance Health's median Other Accumulated Expenses value was $36.1 million (recorded in 2023), while the average stood at $38.5 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 21065.08% in 2023, then plummeted by 5244.32% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Other Accumulated Expenses stood at $26.5 million in 2021, then rose by 14.78% to $30.4 million in 2022, then increased by 15.07% to $35.0 million in 2023, then soared by 34.07% to $46.9 million in 2024, then dropped by 10.22% to $42.1 million in 2025.
  • Its Other Accumulated Expenses stands at $42.1 million for Q3 2025, versus $46.9 million for Q2 2025 and $43.2 million for Q1 2025.